HLX01
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for HLX01, covering 2020-12-17 to 2022-05-09. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 and Rituximab in Combination With CHOP, in Previously Untreated Subjects With CD20+ DLBCL [Phase 3]